Inform Genomics Completes $2.6M Private Financing | GenomeWeb

NEW YORK (GenomeWeb) – Inform Genomics today announced it has raised $2.6 million in a private placement of preferred stock. 

The firm did not say who the participants in the financing were. It said that the proceeds will go toward advancing its lead programs to support cancer care, including OnPart and HSCT/Mucositis; the development of a proprietary analytic platform; and for general corporate uses, including patent filings and working capital. 

OnPart and MSCT/Mucositis are platforms for predicting a patient's risk for developing common chemotherapy-related side effects. 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nucleic Acids Research this week: nanopore sequencing workflow to detect antibiotic resistance in gut microbes, TSSPlant tool, and more.

Because gene-edited organisms can cross borders, Gizmodo wonders whether there should be an international body to govern their use.

HHS Secretary nominee Tom Price is to go in front of the Senate Committee on Health, Education, Labor and Pensions today, NPR's Morning Edition reports.

Prior to being closed, Theranos' Arizona lab failed an inspection by regulators, according to the Wall Street Journal.